|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:CEO
|
gptkb:Siddharth_Mittal
|
|
gptkbp:chairman
|
gptkb:Kiran_Mazumdar-Shaw
|
|
gptkbp:country
|
gptkb:India
|
|
gptkbp:foundedBy
|
gptkb:Kiran_Mazumdar-Shaw
|
|
gptkbp:foundedIn
|
1978
|
|
gptkbp:headquartersLocation
|
gptkb:Bengaluru
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Biocon Limited
|
|
gptkbp:industry
|
gptkb:biotechnology
pharmaceuticals
|
|
gptkbp:ISIN
|
INE376G01013
|
|
gptkbp:listedOn
|
gptkb:NSE
BSE
|
|
gptkbp:location
|
Bangalore, Karnataka, India
|
|
gptkbp:market
|
global
|
|
gptkbp:notableAchievement
|
first Indian company to manufacture and export enzymes to the US and Europe
pioneer in biosimilars in India
|
|
gptkbp:numberOfEmployees
|
over 10,000
|
|
gptkbp:products
|
biosimilars
branded formulations
generic active pharmaceutical ingredients
novel biologics
|
|
gptkbp:revenue
|
over $1 billion (FY 2022-23)
|
|
gptkbp:stockExchange
|
gptkb:NSE
BSE
|
|
gptkbp:stockSymbol
|
gptkb:BIOCON
|
|
gptkbp:subsidiary
|
gptkb:Syngene_International
gptkb:Biocon_Biologics
|
|
gptkbp:type
|
gptkb:public_company
|
|
gptkbp:website
|
https://www.biocon.com/
|
|
gptkbp:bfsParent
|
gptkb:Kiran_Mazumdar-Shaw
|
|
gptkbp:bfsLayer
|
5
|